Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| REVOLUTION MEDICINES, INC.(RVMD) | 0 | 3,233,490 | +3,233,490 | 0 | 92,736 | 56.72% | +92,736 |
| ERASCA, INC.(ERAS) | 11,055,554 | 11,055,554 | 0 | 21,779 | 23,548 | 14.40% | +1,769 |
| VERVE THERAPEUTICS, INC. | 2,008,809 | 2,008,809 | 0 | 26,637 | 28,003 | 17.13% | +1,366 |
| GOSSAMER BIO, INC. | 8,055,916 | 8,055,916 | 0 | 6,709 | 7,351 | 4.50% | +642 |
| SINGULAR GENOMICS SYSTEMS, INC. | 3,798,926 | 3,798,926 | 0 | 1,447 | 1,748 | 1.07% | +300 |
| UNITY BIOTECHNOLOGY, INC. | 1,004,817 | 1,004,817 | 0 | 2,412 | 1,939 | 1.19% | -472 |
| DENALI THERAPEUTICS, INC.(DNLI) | 693,749 | 381,249 | -312,500 | 14,312 | 8,182 | 5.00% | -6,130 |
| EQRX, INC. | 36,335,375 | 0 | -36,335,375 | 80,665 | 0 | — | -80,665 |